Who should not take D-aspartic acid

D-aspartic acid, usually abbreviated DAA, is marketed as a natural testosterone booster. The evidence for that claim is weak and inconsistent, and several groups have good reason to avoid it. This editorial overview sets out who should not take DAA, what the research actually shows, and how to form sensible expectations.

What D-aspartic acid is

Aspartic acid is an amino acid that exists in two mirror-image forms, D and L. The L-form is a common dietary amino acid used in protein building. The D-form, D-aspartic acid, is found in smaller amounts in the body, notably in nerve and endocrine tissues, where it is thought to play a signalling role in the release of certain hormones.

It is this hormonal signalling role that underpins the marketing of DAA as a testosterone booster. In animal and laboratory studies, D-aspartic acid has been shown to influence the release of luteinising hormone and testosterone, which led to the hypothesis that supplementing it might raise testosterone in humans. Whether that translates into a real, useful effect in people is the key question.

DAA is sold as a dietary supplement, typically as a powder or in capsules, and is a common ingredient in "test booster" products aimed at men seeking to raise testosterone naturally. Unlike the prescription hormones covered elsewhere on this site, it is an ordinary supplement, so this article can discuss its use practically.

The purpose here is twofold: to identify who should avoid DAA, and to be honest about how modest and inconsistent the evidence for its headline claim actually is.

What the testosterone evidence really shows

The evidence for DAA as a testosterone booster is mixed and, on balance, unconvincing for healthy, trained men. An early 2009 study reported a rise in testosterone in a group of men after supplementation, generating considerable excitement. But subsequent, better-controlled studies failed to replicate this, and some found no effect.

Notably, one study in resistance-trained men found that DAA did not increase testosterone and, at a higher dose, was associated with a decrease in testosterone — the opposite of the intended effect. This inconsistency is the hallmark of an ingredient whose real-world benefit, if any, is small and unreliable.

Where any effect has been reported, it tends to be in men with lower baseline testosterone or those who are untrained, and even then the changes are often small and short-lived. There is little convincing evidence that DAA produces meaningful, sustained increases in testosterone, muscle mass or strength in healthy, resistance-trained men.

The reasonable conclusion from the body of research is that DAA is, at best, an unreliable and modest influence on testosterone, and at worst without benefit. This uncertainty is important context for the question of who should avoid it: there is little upside to weigh against any potential downside.

Groups who should avoid it

Several groups have clear reasons to avoid DAA. Women, including those who are pregnant or breastfeeding, should not use it: it is marketed for male hormonal effects, the safety data in women and during pregnancy are lacking, and altering hormonal signalling is particularly inadvisable in these situations.

Adolescents and young people under 18 should avoid DAA. Their hormonal systems are still developing, there is no evidence of benefit, and interfering with endocrine signalling during this period is unwise. Hormone-influencing supplements are not appropriate for a developing body.

People with hormone-sensitive conditions — including certain cancers, or endocrine disorders — should avoid DAA unless specifically advised otherwise by a specialist, because a substance that may influence sex-hormone signalling could be relevant to their condition. The same caution applies to anyone undergoing hormonal treatment.

Those with significant kidney or liver conditions should exercise caution with any amino-acid supplement taken in concentrated form and seek advice first. More generally, anyone with a diagnosed medical condition or on regular medication should check with a pharmacist before starting DAA.

Interactions and practical cautions

DAA is not associated with major, well-documented drug interactions, but this partly reflects limited study rather than proven safety. Because it may influence hormonal pathways, it is prudent for anyone taking hormonal medicines, fertility treatments or drugs affecting the endocrine system to discuss it with a clinician first.

There is a particular irony worth noting for the target market. Men take DAA hoping to raise testosterone, yet at least one study suggested higher doses could lower it. For anyone concerned about fertility, this is relevant, since the hormonal axis DAA interacts with also governs sperm production, and the effects are not well characterised.

• Hormonal medicines: discuss with a doctor before combining.
• Fertility concerns: effects on the hormonal axis are uncertain.
• Underlying conditions: check with a pharmacist first.
• Quality: supplement contents and purity vary between brands.

Reported side effects in studies have generally been mild, including occasional headache or irritability, but the data are limited. The absence of a long list of side effects should not be read as proof of safety, given how little rigorous human research exists.

As with all supplements, product quality varies, and some products combine DAA with other active ingredients whose effects and interactions add complexity. Reading the full ingredient list and choosing reputable products reduces, though does not eliminate, this uncertainty.

Sensible expectations

For the healthy adult man who is not in one of the groups above and who chooses to try DAA, the realistic expectation should be low. The weight of evidence suggests little or no reliable benefit for testosterone, muscle or strength in trained individuals, so disappointment is the likely outcome.

Testosterone is far more effectively supported by foundational measures: adequate sleep, maintaining a healthy body-fat level, resistance training, managing stress, and correcting genuine deficiencies such as low vitamin D where present. These have better evidence than any "test booster" supplement.

If a man has symptoms of genuinely low testosterone — persistent fatigue, low libido, loss of muscle, low mood — the appropriate step is not a supplement but a blood test and assessment by a doctor. Low testosterone has medical causes and treatments; a DAA capsule is not among them.

In short, DAA is a supplement with weak evidence, clear groups who should avoid it, and modest expectations even for those who can take it. For most people, the money and effort are better directed at the fundamentals.

Conclusions of the editorial team

D-aspartic acid is marketed on a claim — reliable testosterone boosting — that the evidence does not support, with studies ranging from small benefits in untrained men to an actual reduction at higher doses. That weak and inconsistent evidence means there is little upside to balance against any risk.

Several groups should simply avoid it: women, pregnant and breastfeeding people, under-18s, those with hormone-sensitive conditions and anyone on hormonal treatment. For everyone else, expectations should be low, and the fundamentals of sleep, training and body composition matter far more.

Readers may also find our material on evidence-based ways to support testosterone naturally, on when to get testosterone tested, and on which supplements actually have good evidence useful alongside this overview.

References

1. Topo E, Soricelli A, D'Aniello A, et al. The role and molecular mechanism of D-aspartic acid in the release and synthesis of LH and testosterone in humans and rats. Reprod Biol Endocrinol. 2009;7:120.
2. Melville GW, Siegler JC, Marshall PWM. Three and six grams supplementation of D-aspartic acid in resistance trained men. J Int Soc Sports Nutr. 2015;12:15.
3. Willoughby DS, Leutholtz B. D-aspartic acid supplementation combined with 28 days of resistance training. Nutr Res. 2013;33(10):803–810.
4. Roshanzamir F, Safavi SM. The putative effects of D-aspartic acid on blood testosterone levels: a systematic review. Int J Reprod Biomed. 2017;15(1):1–10.
5. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715–1744.